A Maternal Vaccine Against Group B Streptococcus: Past, Present, and Future
This review article, published in Vaccine, explores the history of the design of maternal vaccines against group B Streptococcus (GBS). GBS is a major cause of morbidity and mortality among neonates. The article notes that though there have been advances in the prevention of invasive neonatal GBS disease through prophylactic antibiotic treatment of pregnant women, the incidence of disease has not changed significantly. The authors argue that vaccination of pregnant women is an important strategy, and that emerging research may influence the future of GBS vaccine design. ABSTRACT ONLY. (Learn how users in developing countries can gain access to free journal articles.)
Author: Chen VL, Avci FY, Kasper DL
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Chen VL, Avci FY, Kasper DL. A Maternal Vaccine Againt Group B Streptococcus: Past, Present, and Future. Vaccine. 2013;31(Suppl 4):D13-D19.
Resource types: Peer-reviewed journal
Diseases/vaccines: Group B Streptococcus (GBS)